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Background: The ability to accurately detect differential resource use between persons of different socioeconomic
status relies on the accuracy of health-needs adjustment measures. This study tests different approaches to
morbidity adjustment in explanation of health care utilization inequity.
Methods: A representative sample was selected of 10 percent (~270,000) adult enrolees of Clalit Health Services,
Israel’s largest health care organization. The Johns-Hopkins University Adjusted Clinical Groups
® were used to
assess each person’s overall morbidity burden based on one year’s (2009) diagnostic information. The odds of
above average health care resource use (primary care visits, specialty visits, diagnostic tests, or hospitalizations)
were tested using multivariate logistic regression models, separately adjusting for levels of health-need using data
on age and gender, comorbidity (using the Charlson Comorbidity Index), or morbidity burden (using the Adjusted
Clinical Groups). Model fit was assessed using tests of the Area Under the Receiver Operating Characteristics Curve
and the Akaike Information Criteria.
Results: Low socioeconomic status was associated with higher morbidity burden (1.5-fold difference). Adjusting for
health needs using age and gender or the Charlson index, persons of low socioeconomic status had greater odds of
above average resource use for all types of services examined (primary care and specialist visits, diagnostic tests, or
hospitalizations). In contrast, after adjustment for overall morbidity burden (using Adjusted Clinical Groups), low
socioeconomic status was no longer associated with greater odds of specialty care or diagnostic tests (OR: 0.95, CI: 0.94-
0.99; and OR: 0.91, CI: 0.86-0.96, for specialty visits and diagnostic respectively). Tests of model fit showed that adjustment
using the comprehensive morbidity burden measure provided a better fit than age and gender or the Charlson Index.
Conclusions: Identification of socioeconomic differences in health care utilization is an important step in disparity
reduction efforts. Adjustment for health-needs using a comprehensive morbidity burden diagnoses-based measure,
this study showed relative underutilization in use of specialist and diagnostic services, and thus allowed for
identification of inequity in health resources use, which could not be detected with less comprehensive forms of
health-needs adjustments.
Background
The link between socioeconomic status (SES) and health
has long been recognized, with lower SES associated
with poorer health [1,2]. With more health needs, low
S E Sp o p u l a t i o n sw o u l db ee x p e c t e dt oc o n s u m em o r e
health services, yet accessing certain types of services is
often impeded by financial and organizational barriers.
Inequitable use of health services has been described
even in countries with universal coverage. In In Israel,
all residents are covered by mandatory health insurance,
financed mainly by a progressive health tax, and pro-
vided by one of four health funds, operating as insurers
and providers. Clalit Health Services is the largest (non-
for-profit) health fund in Israel, with over 3.9 million
enrolees (53% market share), operating services distribu-
ted throughout Israel, including 1500 primary and
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any medium, provided the original work is properly cited.secondary care clinics, 14 hospitals, labs and diagnostic
imaging facilities. Clalit members receive, at the point of
care, free primary care and hospitalization services. Spe-
cialty care and imaging services incur a copayment. Per-
sons of low SES (who receive social security
entitlements) receive a complete or partial waiver for
these copayments, depending on their social security
entitlement status. Despite universal coverage and
copayment waivers, previous Israeli studies have shown
that disadvantaged groups face more barriers to speci-
alty care than the rest of the population [3,4].
Studies from other developed countries have demon-
strated that persons of low economic status utilize less
specialist services than their more affluent counterparts
[5-8], yet findings on pro-rich specialty care use also
exist [9]. Primary care is generally shown to be equitably
distributed in universal coverage health care systems
[6,10], however inequitable primary care use is also
reported [11]. These inconsistent findings may reflect
actual variations in patterns of SES and health care use,
yet they may be a result of differences in measurement
of health needs [12].
Various measures of morbidity are used for case-mix
adjustments in the health care inequity literature. The
most commonly used measures include survey-based
health status measures [6,7], comorbidity indices such as
the Charlson comorbidity index [13], simple morbidity
counts [14], or diagnoses-based morbidity measures [15].
Studies show that the use of a comprehensive survey
based health-needs adjustment measure affects the
degree to which equitable resource use can be assessed
[6,7]. A Dutch study on SES utilization differences has
shown that by controlling for health status (using a sur-
vey-based measure), differences by SES changed mark-
edly for all health services analyzed, as compared to a
basic age-gender adjustment method [16]. Yet, survey-
derived measures are not easily collectable. Moreover,
patient self-reported health status has been shown to dif-
fer between population sub-groups [17,18]. The relative
value of different adjustment measures that are based on
readily available morbidity data (from electronic medical
records or administrative data bases), such as the Charl-
son index, or comprehensive diagnoses-based morbidity
measures, has not been previously assessed.
The aim of this study was to examine the degree to
which adjustment for morbidity using a diagnoses-based
morbidity measure-based on tools of the Johns Hopkins
University Adjusted Clinical Groups
® (ACGs) [19-22],
explains differences in health care use by socioeconomic
status, better than other commonly used health needs
measures. We compared models of SES utilization dif-
ferences, adjusting for overall morbidity burden (using
the ACG system), with models that used age and gender
only, or comorbidity (using the Charlson index).
Methods
Sample and setting
A representative sample of about 10% of all members of
Clalit during the entire year of 2009, including persons
born or those who have died during the year, was
selected. All identifying data were removed. Data on
diagnoses were retrieved from two main sources: hospi-
talization and community physician visits, which repre-
sent the entire experience each patient had within the
Clalit health care system. Diagnoses are routinely elec-
tronically recorded during all medical encounters for
clinical and care management (non-billing) purposes,
and are then stored in a central data warehouse. There-
fore, the entire morbidity profile of each individual was
captured. Clalit’s institutional ethics committee author-
ized the study.
Morbidity groups
The JHU-ACG System takes into consideration the entire
health status of a person-based on individual diagnoses
and, more importantly, combinations of these diagnoses,
and then classifies the population into homogeneous
categories in terms of the overall illness burden [19,20].
The building blocks of the ACG system are diagnostic
codes, age and gender. Each diagnoses assigned to a per-
son during a predetermined period (usually a year) is
coded into one of 32 groups-the Aggregated Diagnostic
Groups (ADGs). The ADG classification (performed by
the software grouper mechanism) is based on the dura-
tion, severity, diagnostic certainty, etiology, and need for
specialty care that is associated with each diagnosis [19].
In this study, the ACG
® Case-Mix System, Version 9.1
software was used [23].
Before applying ADGs to examine socioeconomic dif-
ferences in utilization within Clalit, the applicability of
the ACG system to Israeli data was tested. We per-
formed assessments of the degree to which distribution
of the Clalit sample to ADGs is similar to their distribu-
tions in other countries, and we tested how well ADGs
explain resource use within Clalit, thereby making the
conclusions about SES valid. We compared the distribu-
tion of ADGs in Clalit to data from the Untied States
(US) and Spain, as in both these countries extensive
research and validation of the ACG system has been
conducted and since they reflect a diverse set of health
system types. The Spanish sample is from a study of
Orueta and colleagues [22] on explanation of utilization
of primary care in Spain based on information registered
in medical records. US data came from a sample of 3
million commercially insured persons under the age of
65 from 85 geographically diverse health plans (Mid-
w e s t ,3 5 % ,N o r t h e a s t ,2 1 % ,S o u t h ,3 1 % ,W e s t ,1 3 % ) .
Data were obtained from the PharMetrics Patient-Cen-
tric Data-base, of health plans that submit data in
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Clalit enrolees under the age of 65 (N = 351,558), was
used for the US sample comparisons. The distribution
of ADGs was compared using Pearson’sr[ 2 4 ] .W e
excluded categories that had less than 100 persons
(0.01%) due to small cell size considerations.
As part of the validation tests, examination of the
degree to which morbidity, as measured by the ACG
system, is associated with health care resource use was
tested and compared to other health needs measures.
The adjusted R
2 of several multiple linear regression
models were calculated. The dependent variables were:
number of primary care encounters, number of specia-
list visits, performance of diagnostic imaging tests, and
number of hospitalizations for each person during the
12-month study period. Independent variables included
age and gender, morbidity groups-the 32 ADG dummy
variables, or the Charlson Comorbidity Index (CCI) [25].
The CCI was originally developed as a means of classify-
ing the number and seriousness of about 20 chronic
conditions to predict 1-year mortality based on diag-
noses from medical charts, however, it is widely used to
adjust for comorbidity in explanations of health care use
[26,27]. Data on chronic conditions were obtained from
the Clalit’s Chronic Disease Registry (CCDR), which
aligns information from electronic medical records of
physician visits and hospitalizations, as well as data on
prescription drugs and information from diagnostic and
lab tests. The registry’s classification is verified by indivi-
dual physicians, that request changes in their patients’
chronic illness status in cases of misclassification [28].
Differences by socioeconomic status
To assess differences in health care utilization we used a
sub-sample of adults aged 18 or older (N = 279,241).
We examined the odds of having an above average
number of primary care visits, specialist visits, or diag-
nostic tests performed, or having one or more hospitali-
zation for persons holding a social security waiver
versus all other adults. A social security waiver is pro-
vided to about 10% of the Israeli population receiving
supplemental income (by proof of entitlement) and to
those with a disability benefit, and provides a waiver of
co-payments for specialty visits and diagnostic tests, and
is commonly used as a marker of poor economic status
in Israeli health care reports [29]. We categorized the
waiver variable into two groups: those holding a waiver
due to economic entitlement (1) versus all others (0),
including non-waiver holders and those holding the
waiver due to disability.
Analyses were conducted using three types of logistic
regression models: Models A, control for age and gender
only; Models B, control for age, gender and the comor-
bidity (using the CCI); and Models C control for age,
gender, and morbidity burden (measured by ADGs).
Model fit was assessed using the Akaike Information
Criterion (AIC), indicating better fit for smaller versus
larger AIC values, and the area under the Receiving
Operator Characteristic (ROC) curve, indicating better
fit as the value nears one (score ranges 0.5-1) [30].
To account for the fact that entitlement to a social
security waiver is not a direct measure of socioeco-
nomic status we conducted sensitivity analyses using
two other proxy measures of SES-having supplemen-
tary private insurance (in addition to the mandatory
tax-based insurance) and belonging to a low, medium,
or high socioeconomic area (as measured by the socio-
economic indicator of the Israeli Bureau of Statistics
[31]). To account for nesting of patients within clinics,
analysis involving the area level SES indicator was con-
ducted using the generalized estimating equation [32].
Data analyses were performed using STATA version
10 [33].
Results
During 2009 a total of over 6 million diagnoses from
hospitalizations or community physician visits were
assigned to all persons in the Clalit sample (average of
6.3 distinct diagnoses per person). On average each per-
son was assigned 4.2 morbidity groups (ADGs) (SD 3.2,
range: 0-25, of a possible 32 groups) (Table 1). Social
security waiver holders (adults) had on average of about
1.5 times more morbidity groups assigned than non
waiver holders (6.5 ADGs, SD: 3.8 and 4.3 ADGs, SD:
3.1 respectively). The average CCI score for the total
sample and for the adults sub-sample was 1.2 and 1.6,
respectively (range in each sample 0-22). About 60% of
all enrolees (and about 50% of all adults) had a CCI
score of zero.
Tests of the correlation of the overall distribution of
ADGs in Clalit showed that ADGs are distributed simi-
larly in different populations. The Pearson correlation
was very similar to that of the US and the Spanish sam-
ples (r = 0.89, and 0.95 respectively).
Table 1 Sample characteristics
Total
Sample
(N =
398,537)
Adult Sub-
sample
(N = 279,241)
Age (mean, SD) 35.3 (23.1) 45.8 (19.4)
Gender, female (N, %) 203,652 (51.0) 145,205 (52.0)
Social Security Waiver (N, %) 49,241 (12.4) 40,947 (14.6)
Charlson Comorbidity Index (mean,
SD)
1.19 (2.1) 1.62 (2.3)
Number of ADGs (mean, SD) 4.2 (3.2) 4.7 (3.5)
SD: Standard Deviation
ADG: Aggregate Diagnostic Groups (of possible 32 groups).
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explained the largest percent of variance or in health
care resource use: 23% to 54% of the variation in pri-
mary care physician visits, specialist visits, performance
of diagnostic tests, and hospitalizations. Models that
adjusted for comorbidity (using the CCI) explained only
11-18% of all types of resource use. Age and gender
alone explained only 5-13% of variation in use of the
above health care services.
Differences in resource use by socioeconomic status
Table 3 reports the differences in high resource use
between persons holding a social-security waiver and all
other adult enrolees. Adults holding a social-security
waiver were about twice as likely to have an above aver-
age number of primary care visits, 30% more likely to
have an above average number of specialist visits or
diagnostic tests performed, and more than twice as
likely to be hospitalized at least one, compared with all
other adults.
Table 4 reports the Odds Ratios (OR) and confidence
intervals (CI) for having above average resource use in
persons with a social security waiver compared to all
other adults. Controlling for age and gender only or for
comorbidity (using the CCI), persons of low socioeco-
nomic status (i.e., those holding a waiver) were signifi-
cantly more likely to have above average number of
primary care visits, specialist visits, diagnostic tests per-
formed, and one or more hospitalization. Controlling for
morbidity burden (using ADGs), compared to all other
adults, waiver holders were less likely to have an above
average number of specialist visits or an above average
number of diagnostic tests performed. In all morbidity
burden models (Models C), the likelihood of having an
above average resource use for each type of service
examined was reduced by 17-35% relative to the age
and gender only models (Models A).
Tests of model fit (area under the ROC curve or AIC
tests) indicated a better fit of all morbidity burden mod-
els (Models C; area under the ROC curve: between 0.72-
0.86, indicating good-very good fit) than models control-
ling for age and gender only (Models A; area under the
ROC curve: between 0.66-0.74, indicating a poor-good
fit) or the comorbidity (CCI) models (Models B; area
under the ROC curve: between 0.67-0.77, indicating a
poor-good fit) [23] (Table 5).
Analysis conducted with the two other SES measures
(having supplemental insurance or area level SES)
showed similar results-i.e., controlling for age, gender,
and morbidity burden, the more socially deprived were
s i g n i f i c a n t l ym o r el i k e l yt oh a v ea na b o v ea v e r a g en u m -
ber of primary care visits or one or more hospitaliza-
tions, and significantly less likely to have an above
average number of specialist visits or diagnostic tests
performed, than those with supplemental private insur-
ance or higher SES (data not shown). All models that
accounted for overall morbidity burden resulted in a
better fit than adjustments using the comorbidity mea-
sure or age and gender only.
Discussion
Our findings show that accounting for overall morbidity
levels with a comprehensive measure based on the com-
bination of all types of diagnoses, inequity in various
types of health care resource use could be identified.
Persons of low economic status were more likely than
those of higher economic status to be high users of pri-
mary care services, more likely to be hospitalized at
least once during the 12-month study period, and were
less likely to be high users of specialty care and diagnos-
tic imaging services.
Comparisons between models that used different
adjustment measures showed that morbidity burden
provides a better explanation of differential resource use
than other commonly used measures. Adjustments
Table 2 Coefficients of determination (r2) of the multiple linear regression models explaining resource use
Primary care visits Specialist visits Diagnostic tests Hospitalizations
Age and gender 0.13 0.12 0.13 0.05
Charlson Comorbidity Index, age, gender 0.18 0.13 0.15 0.11
ADGs, age, gender 0.54 0.45 0.37 0.24
ADG: Aggregate Diagnostic Groups (dummy variables, non-mutually exclusive).
Table 3 Percent with high service use by socioeconomic status*
Adults with Social Security Waiver All other adults
Above average number of primary care visits 63% 34%
Above average number of specialist visits 42% 31%
Above average number of diagnostic tests 38% 28%
One or more hospitalizations 16% 7%
* p-value from chi square tests: p < 0.001 for all comparisons
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Adults
with
Social
Security
Waiver
(vs. all
other
adults)
Above average number of primary
care visits
Above average number of
specialist visits
Above average number of
diagnostic tests
One or more
hospitalizations
Model A: Adjusting for age and gender
Odds
ratio
(95%
CI)
1.92
(1.87-1.97)
1.13
(1.10-1.57)
1.11
(1.08-1.37)
1.67
(1.62-1.73)
Model B: Adjusting for age, gender and the Charlson Comorbidity Index
Odds
ratio
(95%
CI)
1.62
(1.58-1.66)
1.04
(1.01-1.06)
1.05
(1.03-1.08)
1.38
(1.33-1.42)
Model C: Adjusting for age, gender, and morbidity using ADG categories
Odds
ratio
(95%
CI)
1.64
(1.60-1.69)
0.95
(0.94-0.99)
0.91
(0.86-0.96)
1.24
(1.20-1.29)
ADG: Aggregate Diagnostic Groups (dummy variables, non-mutually exclusive).
CI: Confidence Interval
Table 5 Socioeconomic class and high service use: predictive accuracy of alternative morbidity models
Adults
with
Social
Security
Waiver
(vs. all
other
adults)
Above average number of
primary care visits
Above average number of
specialist visits
Above average number of
diagnostic tests
One or more
hospitalizations
Model A: Adjusting for age and gender
Area
under
the
ROC
curve
0.74 0.66 0.66 0.67
AIC 315900 331209 262971 150883
Model B: Adjusting for age, gender and the Charlson Comorbidity Index
Area
under
the
ROC
curve
0.77 0.67 0.67 0.72
AIC 307183 329009 262267 142501
Model C: Adjusting for age, gender, and morbidity using ADG categories
Area
under
the
ROC
curve
0.85 0.77 0.72 0.86
AIC 254608 290254 247195 117215
ROC: Receiver Operating Characteristics
ADG: Aggregate Diagnostic Groups (dummy variables, non-mutually exclusive).
AIC: Akaike Information Criteria
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mated the difference in utilization between persons
from low and high SES. Moreover, adjusting for age and
gender or the Charlson index misleadingly showed that
persons of low SES are more likely to have higher utili-
zation of specialists and diagnostic services. Adjustments
using the morbidity burden measure (ADGs) revealed a
reverse relationship, more accurately explaining differ-
ences in resource use (as shown by the tests of model
fit).
Other countries and health systems with universal
coverage face similar challenges-differences in health
care use by SES are reported, with reports on pro-rich
inequity in specialty care use [5-8] and in performance
of diagnostic imaging tests [15,34]. Studies on primary
care use by SES are mixed, with some showing an equi-
table (i.e., needs-based) distribution across SES groups
[6,10], while others support the findings reported here,
showing that person of poorer economic status use
more primary care services than their richer counter-
parts [35]. Higher rates of hospitalizations of those from
lower SES were also found by others [14]. Our study
supports these findings, and adds to current knowledge
by showing that the choice of health-need adjustment
measure can affect the magnitude and accuracy of iden-
tification of gaps in service use.
Countries and health care systems differ in benefit
design, patient-cost-sharing, and the role of private
insurance, and the reasons and magnitude of inequalities
vary. Yet, common findings on utilization inequity in
universal coverage systems suggest that implementation
of universal coverage principles deserves further consid-
eration. A possible explanation for the inequitable use of
health services reported here is that, as reported also by
others, persons of low SES face non-financial barriers to
health service use [3,4]. These barriers may include
poorer availability of services, cultural and language
gaps that may affect minorities, who constitute large
percentages of low SES populations, or differences in
preferences. Future research is required to test whether
differences in use reflect the level of needed care by per-
sons from diverse SES groups (i.e., whether underutiliza-
tion or overutilization exists) and to assess the degree to
which inequity reduction programs succeed in minimiz-
ing unwarranted gaps.
A potential criticism on the use of diagnoses-based
measures, such as ADGs, is that they may be biased due
to their reliance on data registered during patient visits,
and thus non-clinically measured aspect of health and
underutilization may affect the completeness of data. A
recent Canadian study addressed this potential short-
coming by examining the contribution of survey-derived
indicators of health status to explanatory models of phy-
sician service use based on morbidity adjustment using
the ACG system [36]. Adjustments for health status in
that study did not contribute significantly to models on
the basis of the diagnoses-based ACG measures. As
availability of survey data, in comparison to routinely
collected administrative and clinical data, may be lim-
ited, it is important to acknowledge the benefits of using
diagnoses-based measures for planning, reimbursement,
and research.
Assessing healthcare utilization patterns among low
SES groups is a key step in planning health inequity-
reduction strategies in healthcare organizations. To
reduce inequities in health and in the delivery of health
care, Clalit has laid out in 2008 an organization-wide
strategic plan that addresses health care workforce, qual-
ity of care and utilization differences between low and
high SES groups [37]. Examination of differences in use
of health care services, based on robust measures of
need, as reported here, can direct organizational efforts
by suggesting areas of potential inequitable access to
care.
Diagnoses-based morbidity measures, which classify
the population according to diagnoses from all medical
encounters, are increasingly being used by health care
organizations worldwide for various applications, includ-
ing equitable allocation of resources, assessments of pro-
viders’ performance, care management, and for research
and evaluation [28,38,39]. Clalit Health Services, mainly
due to historical reasons [40], has a significant overre-
presentation of underprivileged populations-low socioe-
conomic groups, minorities, new immigrants, and
persons with disabilities [41]. Clalit has developed in
recent years various case-mix tools for medical, eco-
nomic and administrative purposes. A recent study has
demonstrated the feasibility and validity of using ACGs
in Clalit [42]. Our cross-national comparisons, as well as
studies from other countries [43-45], show that ACGs
provide robust classification of morbidity across differ-
ent countries with markedly different health care sys-
tems. Moreover, our results show that ACGs explain a
large percent of resource use at Clalit, similar to reports
from other countries; ACGs have been shown to explain
53-59% of the variation in primary care visits in Spain
[22], 41-58% of variation in ambulatory visits in Taiwan
[46], and 32-59% of ambulatory visits in the US [19].
A potential limitation of any diagnoses-based system is
the quality of the diagnostic coding. The accuracy of the
diagnoses has not been systematically estimated here,
however, the similarity between the ACGs’ distributions
in different countries suggests that coding is not a
major limitation in Clalit. Additionally, the JHU-ACG
system is relatively robust and minor differences in cod-
ing do not necessarily affect the system’sg r o u p i n g s ,
which are based on types of diagnoses and health states
and not on specific diagnoses and diseases.
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only a proxy measure and does not incorporate impor-
tant information on education, income and wealth com-
p o n e n t s[ 4 7 ] .T oa d d r e s st h i sw eh a v ee x a m i n e d
different proxies for individual SES, all leading to the
same results regarding the direction, magnitude and sig-
nificance of difference between those with lower versus
higher SES.
Additionally, our results may not be representative of
differences in utilization between socioeconomic groups
in other countries. Health care systems world-wide dif-
fer in benefit design, patient-cost-sharing, and the role
of private insurance. Yet, our main finding, i.e., that
adjustment for morbidity using a robust diagnoses-based
measure allows for a more accurate assessment of
inequity in resource use is of relevance to other coun-
tries and health systems. Finally, this study only exam-
ines how well morbidity, as measured by the ACG
system, explains actual service use, rather than what
ought to have been provided based on patients’ needs.
Future studies are needed to test whether adjustment
for additional factors that define health care need (e.g.,
proximity to healthcare facilities or patient care seeking
behaviours) provide additional insight into the reasons
for differences in healthcare use.
Conclusions
Relative to all other enrolees, persons of low socioeco-
nomic status were less likely to be high users of speci-
alty care and imaging services, a phenomenon identified
only with the use of a robust health-needs measure.
Using routinely recorded data from electronic medical
r e c o r d s ,t h eJ H U - A C GS y s t e mi saf e a s i b l ea n dv a l i d
method to account for the morbidity level of an Israeli
population, strongly associated with different types of
healthcare services utilization. Accurate adjustment to
morbidity level afforded by this system, allows new
insights on differences in healthcare services utilization
between population sub-groups.
With the launching of a new inequity reduction strat-
egy within Clalit, accurate assessment of these differences
is of considerable importance, as assessment of inequal-
ities in health and health care, care management and
resource allocation can be performed more precisely and
fairly. Further research is needed to test these differences
in other Israeli populations as well as in other countries
and to better understand the possible contribution of dif-
ferences in utilization by SES to health outcomes.
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